Buffett Says Valeant’s Business Model Proved ‘Enormously Flawed’
Alert: HALISTER
Source: BN (Bloomberg News)
Tickers
BRK/A US (Berkshire Hathaway Inc)
VRX CN (Valeant Pharmaceuticals International Inc)
People
Warren Buffett (Berkshire Hathaway Inc)
Benjamin Graham (Graham-Newman Corp)
Charles Munger (Berkshire Hathaway Inc)
David Poppe (Ruane Cunniff & Goldfarb Inc)
Garrison Morfit (ValueAct Capital Management LLC)
To de-activate this alert, click here
To modify this alert, click here
UUID: 7947283
Alert: HALISTER
Source: BN (Bloomberg News)
Tickers
BRK/A US (Berkshire Hathaway Inc)
VRX CN (Valeant Pharmaceuticals International Inc)
People
Warren Buffett (Berkshire Hathaway Inc)
Benjamin Graham (Graham-Newman Corp)
Charles Munger (Berkshire Hathaway Inc)
David Poppe (Ruane Cunniff & Goldfarb Inc)
Garrison Morfit (ValueAct Capital Management LLC)
To de-activate this alert, click here
To modify this alert, click here
UUID: 7947283